GCG and type 2 diabetes mellitus: The beneficial properties of GLP-1 have led to the development of six FDA-approved GLP-1RAs (e.g., Rybelsus and liraglutide) for the treatment of type 2 diabetes (Hedrington and Davis, 2019).